Smith, J. D., Baillie, J., Baglin, T., Griffiths, G. O., Casbard, A., Cohen, D., . . . Noble, S. I. (2014). A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective Anticoagulation Length with low molecular weight heparin In the treatment of Cancer Associated Thrombosis (ALICAT): Study protocol for a mixed-methods study. BioMed Central.
Citação norma ChicagoSmith, Joanna D., et al. A Feasibility Study to Inform the Design of a Randomized Controlled Trial to Identify the Most Clinically and Cost Effective Anticoagulation Length With Low Molecular Weight Heparin In the Treatment of Cancer Associated Thrombosis (ALICAT): Study Protocol for a Mixed-methods Study. BioMed Central, 2014.
Citação norma MLASmith, Joanna D., et al. A Feasibility Study to Inform the Design of a Randomized Controlled Trial to Identify the Most Clinically and Cost Effective Anticoagulation Length With Low Molecular Weight Heparin In the Treatment of Cancer Associated Thrombosis (ALICAT): Study Protocol for a Mixed-methods Study. BioMed Central, 2014.